You are here

News

Comment

Discuss

Coverage of the latest news and updates from ongoing clinical trials from various sources.

November 28, 2016

The Stem Cell Network (SCN) announced funding of $9 million for innovative stem cell and regenerative medicine research that will help translate discoveries into better health and economic growth for Canadians.

November 28, 2016

Cell reprogramming does not happen exactly as we thought. A team from the Spanish National Cancer Research Centre (CNIO), Madrid, has shown that tissue damage is a relevant factor for cells to go back to an embryonic state.

November 23, 2016

Researchers have developed a gel for growing miniaturized body organs that can be used in clinical diagnostics and drug development. Organoids are miniature organs that can be grown in the lab from a person's stem cells.

November 22, 2016

Among several studies on brain cancer released in November was one focusing on children diagnosed with the brain tumor malignant glioma, a condition that often has a very poor prognosis.

November 22, 2016

Glioblastoma multiforme remains the most common and highly lethal brain cancer and is known for its ability to relapse.

November 16, 2016

Researchers at the University of Michigan have transplanted lab-grown mini lungs into immunosuppressed mice where the structures were able to survive, grow and mature.

November 14, 2016

The California Institute of Regenerative Medicine (CIRM) has issued a call for applications for two new rounds of funding for stem cell research.

November 14, 2016

Scientists have identified two chemicals that improve their ability to transform scar tissue in a heart into healthy, beating heart muscle. The new discovery advances efforts to find new and effective treatments for heart failure.

November 10, 2016

New research explains how metastatic breast cancer cells might use bone marrow-derived mesenchymal stem cells (MSCs) to help them spread to bone tissue.

November 10, 2016

The prognosis for patients diagnosed with scleroderma, an autoimmune disease characterized by fibrosis of the skin, is not typically a rosy one. With limited treatment options available, those suffering from the disorder can face disabling hardening and tightening of their skin.

Pages